1. World Health Organization (2022) In < https://www.who.int/en/news- room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis), accessed in July
2. Martín-Escolano J, Medina-Carmona E, Martín-Escolano R Chagas disease: current view of an ancient and global chemotherapy challenge. ACS Infect. Dis. 6:2830–2843., Martín-Escolano J, Marín C, Rosales MJ, Tsaousis AD, Medina-Carmona E, Martín-Escolano R (2020) (2022) Chagas disease: current view of an ancient and global chemotherapy challenge. ACS Infect. Dis. 8:1107–1115. https://doi.org/10.1021/ acsinfecdis.2c00123
3. Drug discovery for Chagas disease: a viewpoint;Kratz JM;Acta Trop,2019
4. Ribeiro V, Dias N, Paiva T, Hagström-Bex L, Nitz N, Pratesi R, Hecht M (2020) Current trends in the pharmacological management of Chagas disease. IJP: Drugs and Drug Resistance.12:7–17. doi: 10.1016/j.ijpddr.2019.11.004. Giarolla J, Ferreira EI (2015) Drug design for neglected disease in Brazil. Mini-Reviews Med. Chem. 15:219–241. https://doi.org/10.2174/ 138955751503150312122523
5. Nitroheterocyclic derivatives: privileged scaffold for drug development against Chagas disease;Scarim CB;Med Chem Res,2019